FDNA

FDNA is a healthcare technology company focused on AI-powered tools for diagnosing and managing rare genetic and developmental disorders. Founded in 2011, FDNA utilizes advanced artificial intelligence and next-generation phenotyping technologies to analyze complex physiological data, including facial images, to provide actionable genomic insights. The company aims to enhance genetic healthcare by offering innovative decision support and care management tools that facilitate earlier and more accurate detection of genetic conditions.

FDNA's offerings include the Face2Gene platform, which assists healthcare providers in diagnosing genetic conditions through AI analysis of patient photos and clinical data. The company also provides digital interfaces that streamline diagnostic workflows, care management tools that connect patients and providers, and a data clearing house that enhances interoperability among various stakeholders in the healthcare ecosystem. With a commitment to clinical integrity and data security, FDNA serves a wide range of users, including parents, healthcare providers, researchers, and pharmaceutical companies, helping to improve patient outcomes globally.